Report overview
Acute kidney injury therapeutics is the cure to the acute kidney injury that is a group of clinical syndromes that refers to sudden (within 1-7d) and sustained (> 24h) sudden declines in renal function. It is defined as an increase in serum creatinine (SCr) of at least 0.5mg / dl 1 and manifested as nitrogen. Plasmaemia, water-electrolyte and acid-base balance and systemic symptoms can be accompanied by oliguria (<400ml / 24h or 17ml / h) or anuria (<100ml / 24h).
This report aims to provide a comprehensive presentation of the global market for Acute Kidney Injury Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Kidney Injury Therapeutics. This report contains market size and forecasts of Acute Kidney Injury Therapeutics in global, including the following market information:
Global Acute Kidney Injury Therapeutics Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Acute Kidney Injury Therapeutics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Non-drug Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Acute Kidney Injury Therapeutics include Quark Pharmaceuticals, Alloksys, Angio Biomedica Corporation, Stealth Bio Therapeutics, Silver Creek Pharmaceuticals, AM Pharma Holding, Ischemix, Biomerieux and A1M Pharma, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Acute Kidney Injury Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Kidney Injury Therapeutics Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Acute Kidney Injury Therapeutics Market Segment Percentages, by Type, 2023 (%)
Non-drug
Drugs
Global Acute Kidney Injury Therapeutics Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Acute Kidney Injury Therapeutics Market Segment Percentages, by Application, 2023 (%)
Hospitals
Clinic
Other
Global Acute Kidney Injury Therapeutics Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Acute Kidney Injury Therapeutics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute Kidney Injury Therapeutics revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Acute Kidney Injury Therapeutics revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Quark Pharmaceuticals
Alloksys
Angio Biomedica Corporation
Stealth Bio Therapeutics
Silver Creek Pharmaceuticals
AM Pharma Holding
Ischemix
Biomerieux
A1M Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acute Kidney Injury Therapeutics, market overview.
Chapter 2: Global Acute Kidney Injury Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Acute Kidney Injury Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acute Kidney Injury Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
